FDA.report

Application 209688

Type
ANDA
Sponsor
VITRUVIAS THERAP

Related Records

Application Products

ProductDrugIngredientFormStrengthReference drugReference standard
001POTASSIUM CHLORIDEPOTASSIUM CHLORIDETABLET, EXTENDED RELEASE;ORAL10MEQNoNo
002POTASSIUM CHLORIDEPOTASSIUM CHLORIDETABLET, EXTENDED RELEASE;ORAL20MEQNoNo

NDC Listings For This Application

NDCNameNonproprietary nameLabelerMarketing categoryStatus
43826-025Potassium ChloridePotassium ChlorideBora Pharmaceutical Laboratories Inc.ANDACurrent
43826-025Potassium ChloridePotassium ChlorideBora Pharmaceutical Laboratories Inc.ANDACurrent
43826-025Potassium ChloridePotassium ChlorideBora Pharmaceutical Laboratories Inc.ANDACurrent
43826-026Potassium ChloridePotassium ChlorideBora Pharmaceutical Laboratories Inc.ANDACurrent
43826-026Potassium ChloridePotassium ChlorideBora Pharmaceutical Laboratories Inc.ANDACurrent
43826-026Potassium ChloridePotassium ChlorideBora Pharmaceutical Laboratories Inc.ANDACurrent
69680-133Potassium ChloridePotassium ChlorideVitruvias TherapeuticsANDACurrent
69680-133Potassium ChloridePotassium ChlorideVitruvias TherapeuticsANDACurrent
69680-133Potassium ChloridePotassium ChlorideVitruvias TherapeuticsANDACurrent
69680-134Potassium ChloridePotassium ChlorideVitruvias TherapeuticsANDACurrent
69680-134Potassium ChloridePotassium ChlorideVitruvias TherapeuticsANDACurrent
69680-134Potassium ChloridePotassium ChlorideVitruvias TherapeuticsANDACurrent
70934-974Potassium ChloridePotassium ChlorideDenton Pharma, Inc. DBA Northwind PharmaceuticalsANDACurrent